XBiotech Inc
XBIT
Market Cap$84.45M
Close$
$5.33
92.5% upside
Current Fair Value
92.5% upsideUndervalued by 92.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $84.45 Million |
|---|---|
| Enterprise Value | $-77,976,071.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.26 |
| Beta | 0.97 |
| Outstanding Shares | 30,460,980 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.19 |
|---|---|
| PEG | 6.87 |
| Price to Sales | - |
| Price to Book Ratio | 0.55 |
| Enterprise Value to Revenue | -29.76 |
| Enterprise Value to EBIT | 1.84 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | -0.13 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About XBiotech Inc
CEO: John Simard